Savulescu Camelia, Jiménez-Jorge Silvia, Delgado-Sanz Concha, de Mateo Salvador, Pozo Francisco, Casas Inmaculada, Larrauri Amparo
Institute of Health Carlos III, National Centre of Epidemiology, c/Monforte de Lemos No. 5, 28029 Madrid, Spain.
Institute of Health Carlos III, National Centre of Epidemiology, c/Monforte de Lemos No. 5, 28029 Madrid, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Vaccine. 2014 Jul 31;32(35):4404-4411. doi: 10.1016/j.vaccine.2014.06.063. Epub 2014 Jun 23.
We used data provided by the Spanish influenza surveillance system to measure seasonal influenza vaccine effectiveness (VE) against medically attended cases, laboratory confirmed with the predominately circulating influenza virus over eight seasons (2003-2011).
Using the test-negative case-control design, we compared the vaccination status of swabbed influenza-like illnesses (ILI) patients who were laboratory confirmed with predominantly circulating influenza strain in the season (cases) to that of ILI patients testing negative for any influenza (controls). Data on age, sex, vaccination status and laboratory results were available for all seasons. We used logistic regression to calculate adjusted influenza VE for age, week of swabbing, Spanish region and season. We calculated the influenza VE by each season and pooling the seasons with the same predominant type/subtype.
Overall influenza VE against infection with A(H3N2) subtype (four seasons) was 31 (95% confidence interval (CI):10; 48). For seasonal influenza A(H1N1) (two seasons), the effectiveness was 86% (95% CI: 65; 94). Against B infection (three seasons), influenza VE was 47% (95% CI: 27; 62).
The Spanish influenza surveillance system allowed estimating influenza VE in the studied seasons for the predominant strain. Strengthening the influenza surveillance will result in more precise VE estimates for decision making.
我们利用西班牙流感监测系统提供的数据,来衡量季节性流感疫苗针对有医疗就诊记录、经实验室确认感染在八个季节(2003 - 2011年)中主要流行的流感病毒的病例的有效性(VE)。
采用检测阴性病例对照设计,我们将在该季节经实验室确认感染主要流行流感毒株的拭子采样流感样疾病(ILI)患者(病例)的疫苗接种状况,与任何流感检测均为阴性的ILI患者(对照)的疫苗接种状况进行比较。所有季节均有年龄、性别、疫苗接种状况和实验室检测结果的数据。我们使用逻辑回归来计算针对年龄、采样周、西班牙地区和季节调整后的流感疫苗有效性。我们按每个季节计算流感疫苗有效性,并将具有相同主要型别/亚型的季节合并计算。
针对A(H3N2)亚型感染(四个季节)的总体流感疫苗有效性为31%(95%置信区间(CI):10;48)。对于季节性甲型H1N1流感(两个季节),有效性为86%(95%CI:65;94)。针对B型感染(三个季节),流感疫苗有效性为47%(95%CI:27;62)。
西班牙流感监测系统能够估计所研究季节中主要毒株的流感疫苗有效性。加强流感监测将能得出更精确的疫苗有效性估计值,以用于决策。